Copyright © Inderes 2011 - present. All rights reserved.

Chordate Medical Holding

0.60 SEK

-2.60 %

Less than 1K followers

CMH

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

-2.60 %
-86.67 %
-90.71 %
-90.91 %
-92.39 %
-95.56 %
-99.74 %
-99.61 %
-99.96 %

Chordate Medical Holding is a medical technology company that has developed, patented and CE-marked Ozilia® Migraine, a neuromodulatory and drug-free treatment technique for chronic migraine and chronic rhinitis. The treatment has proven efficacy according to a clinical study and is marketed in selected markets in the EU and the Middle East. The company is headquartered in Kista.

Read more
Market cap
1.62M SEK
Turnover
2.08K SEK
Revenue
660K
EBIT %
-4,159.09 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
5.12
2025

Interim report Q3'25

8.12
2025

Extraordinary general meeting '25

27.2
2026

Annual report '25

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.